GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Althea Group Holdings Ltd (OTCPK:AHGHF) » Definitions » 14-Day RSI

Althea Group Holdings (Althea Group Holdings) 14-Day RSI : N/A (As of May. 22, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Althea Group Holdings 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-22), Althea Group Holdings's 14-Day RSI is N/A.

The industry rank for Althea Group Holdings's 14-Day RSI or its related term are showing as below:

AHGHF's 14-Day RSI is not ranked *
in the Drug Manufacturers industry.
Industry Median: 49.32
* Ranked among companies with meaningful 14-Day RSI only.

Competitive Comparison of Althea Group Holdings's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Althea Group Holdings's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Althea Group Holdings's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Althea Group Holdings's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Althea Group Holdings's 14-Day RSI falls into.



Althea Group Holdings  (OTCPK:AHGHF) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Althea Group Holdings  (OTCPK:AHGHF) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Althea Group Holdings 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Althea Group Holdings's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Althea Group Holdings (Althea Group Holdings) Business Description

Traded in Other Exchanges
Address
360 Elizabeth Street, Suite 2, Level 50, Melbourne, VIC, AUS, 3000
Althea Group Holdings Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates in three reportable segments Pharmaceutical Cannabis, Recreational Cannabis, and Corporate in which it generates the majority of its revenue from Pharmaceutical Cannabis. It operates into four geographic segments: Australia, the United Kingdom, Canada, and others. The company earns key revenue from Australia and through the sale of medicinal cannabis products.

Althea Group Holdings (Althea Group Holdings) Headlines